The goal of this summit is to improve performance, diagnosis, and treatment of MDS patients. Participants will actively engage in multidisciplinary, interactive small-group activities, including:
- Case-based tumor board discussions
- Identifying the new role of molecular testing
- Distinguishing morphologic mimics from MDS
- Assessing low-and-high-grade MDS
- Applying the new prognostic scoring system to patients
Who Should Attend?
- Hematologists/Oncologists
- Hematopathologists
- General Pathologists
- Hematology & Oncology Nurse Practitioners
- Physician Assistants
- Medical Laboratory Professionals
- Pathologists’ Assistants
